Medical Device News Magazine

Branded Legacy Invests Heavily in Innovation and Growth with $540,000 Expansion

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Branded Legacy, Inc (OTC-PINK: BLEG), a prominent player in the biotech industry, proudly announces a substantial investment aimed at expanding its production capabilities and elevating its product offerings. This strategic initiative underscores Branded Legacy’s unwavering commitment to innovation, quality, and customer satisfaction. The expansion project is set to infuse over $500,000 worth of inventory into the company, reinforcing its position as a leader in the market.

The investment encompasses several key areas:

1. Raw Materials and Precursors: Branded Legacy Inc. has allocated $25,000 towards the procurement of top-quality raw materials and precursors. This financial commitment ensures that the company maintains the highest standards in its product formulations.

2. Hardware Purchases: In a dedicated effort to remain at the forefront of technological advancements, Branded Legacy has invested $10,000 in state-of-the-art hardware. This strategic move not only enhances production efficiency but also exemplifies the company’s dedication to staying ahead in the industry.

3. Inventory Expansion –

Preloaded Carts with Batteries: Branded Legacy Inc. has acquired the hardware and raw materials necessary to manufacture 2,500 preloaded carts with batteries, boasting a total estimated value of $105,000. These preloaded carts are designed to provide customers with a convenient and high-quality vaping experience.

510 Cartridges: The company has also made a significant investment in the production of 2,500 510 cartridges, with a total value of $75,000. These cartridges are renowned for their exceptional performance and compatibility with various vaping devices.

Tinctures: Branded Legacy is expanding its tincture production capacity by procuring the resources to manufacture 10,000 15-30 ml tinctures, with an estimated value of $400,000. These tinctures offer a versatile and potent solution for those seeking the benefits of cannabinoids in their daily lives.

Formulated Products: In addition to the ready-to-sell inventory, Branded Legacy Inc. has earmarked $100,000 in raw materials to fulfill various product orders as needed. These products are poised to set new standards in the industry, catering to the evolving needs of consumers.

This significant investment not only bolsters Branded Legacy’s market position but also underscores its unwavering commitment to providing premium-quality products to its valued customers. With a steadfast focus on innovation and excellence, Branded Legacy Inc. remains a trusted and pioneering name in the cannabis and wellness industry.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”